SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,231.00    7.00 (0.57%)
Bid:
1,229.00
Ask:
1,230.00
Spread: 1.00 (0.081%)
Market Cap: £858.56m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Director/PDMR Shareholding

8 Dec 2017 07:00

RNS Number : 7624Y
CVS Group plc
08 December 2017
Β 

CVS Group plc

("CVS" or the "Company")

Β 

Β 

Director/PDMR and PCA Shareholding

Β 

CVS, the UK's leading provider of integrated veterinary services, announces that it was notified on 7 December 2017 that on 7 December 2017, Richard Connell, a Non-executive Director of the Company, purchased 10,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares").

Β 

As a result, Mr Connell holds 107,870 Ordinary Shares, representing 0.17 per cent of the total voting rights of the Company. Mr Connell's total interest in the Company, including his wife's holding, is 110,000 Ordinary Shares, representing 0.17 per cent of the total voting rights of the Company.

Β 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Richard Connell

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

PDMR (Non-executive Director)

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

CVS Group plc

b)

Β 

LEI

Β 

Β 

213800J41XDQ2NX48O05

Β 

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary shares of 0.2 pence each

Β 

Β 

GB00B2863827

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Purchases via:

(i) Own account 7,500

(ii) SIPP 2,061

(iii) ISA 439

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

863.5p

587

893.449p

4,413

919.5275p

2,061

919.5275p

439

946.5p

2,500

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

Β 

10,000

Β 

Β 

911.473 pence

e)

Β 

Date of the transaction

Β 

Β 

7 December 2017

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange (XLON)

Β 

Β 

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director

Β 

Tel: 01379 644 288

Β 

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Liz Yong

Tel: 020 7496 3000

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHEADAXEEXXFAF
Date   Source Headline
24th Sep 20207:00 amRNSFinal Results for the year ended 30 June 2020
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20207:00 amRNSExercise of Options
18th Aug 20203:54 pmRNSHolding(s) in Company
31st Jul 20207:00 amRNSExercise of Options
24th Jul 20207:00 amRNSTrading Update
16th Jul 20207:00 amRNSBoard Appointment
30th Jun 202011:15 amRNSExercise of Options
26th Jun 20207:00 amRNSChange of Company Secretary
9th Jun 202012:29 pmRNSDirector/PDMR Shareholding
1st Jun 202011:50 amRNSExercise of Options
7th May 20209:10 amRNSHolding(s) in Company
30th Apr 202010:25 amRNSExercise of Options
14th Apr 20204:00 pmRNSHolding(s) in Company
9th Apr 202012:23 pmRNSHolding(s) in Company
2nd Apr 20202:29 pmRNSHolding(s) in Company
31st Mar 20201:42 pmRNSExercise of Options
30th Mar 202011:45 amRNSDirector/PDMR Shareholding
27th Mar 20202:52 pmRNSDirector/PDMR Shareholding
27th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Mar 20209:54 amRNSFormatting Replacement: Interim Results
27th Mar 20207:00 amRNSInterim Results
20th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSHolding(s) in Company
12th Mar 20209:34 amRNSHolding(s) in Company
9th Mar 20205:01 pmRNSHolding(s) in Company
9th Mar 20209:18 amRNSHolding(s) in Company
6th Mar 20205:27 pmRNSHolding(s) in Company
6th Mar 20202:47 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSExercise of Options
7th Feb 20207:00 amRNSTrading Update
31st Jan 20205:47 pmRNSOption exercise and block listing update
27th Jan 20204:12 pmRNSHolding(s) in Company
24th Jan 20204:22 pmRNSHolding(s) in Company
22nd Jan 20205:08 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSHolding(s) in Company
10th Jan 20203:46 pmRNSLong Term Incentive Plan Awards - replacement
10th Jan 20209:27 amRNSHolding(s) in Company
8th Jan 20203:57 pmRNSLong Term Incentive Plan Awards
7th Jan 20204:58 pmRNSHolding(s) in Company
6th Jan 202012:02 pmRNSPrice Monitoring Extension
2nd Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20199:29 amRNSHolding(s) in Company
20th Dec 20193:15 pmRNSLong Term Incentive Plan Awards
12th Dec 20199:39 amRNSHolding(s) in Company
2nd Dec 201912:17 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSBoard Appointments
29th Nov 20197:00 amRNSResult of AGM
28th Nov 20197:00 amRNSAnnual General Meeting Statement
21st Nov 201910:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.